Physiology of nucleoside transporters: back to the future. . . .

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Physiology

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/physiol.00036.2007PMID 18268364
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inosine and equilibrative nucleoside transporter 2 contribute to hypoxic preconditioning in the murine cardiomyocyte HL-1 cell line.

  2008cited by this paper
• Characterization of adenosine transport in H9c2 cardiomyoblasts.

  2007cited by this paper
• Activation of the A1 adenosine receptor increases insulin-stimulated glucose transport in isolated rat soleus muscle.

  2007cited by this paper
• Adenosine deaminase 1 and concentrative nucleoside transporters 2 and 3 regulate adenosine on the apical surface of human airway epithelia: implications for inflammatory lung diseases.

  2007cited by this paper
• Physiological Roles of Vascular Nucleoside Transporters

  2007cited by this paper
• Tryptophan, adenosine, neurodegeneration and neuroprotection

  2007cited by this paper
• Adenosinergic cardioprotection: multiple receptors, multiple pathways.

  2007cited by this paper
• Different signaling pathways utilized by insulin to regulate the expression of ENT2, CNT1, CNT2 nucleoside transporters in rat cardiac fibroblasts.

  2007cited by this paper
• The optimization of sample treatment for spectral karyotyping with applications for human tumour cells

  2007cited by this paper
• The type 1 equilibrative nucleoside transporter regulates anxiety‐like behavior in mice

  2007cited by this paper
• The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs

  2007cited by this paper
• Comparative gene expression profiles of intestinal transporters in mice, rats and humans.

  2007cited by this paper
• Adenosine, an endogenous distress signal, modulates tissue damage and repair

  2007cited by this paper
• Concentrative nucleoside transporters (CNTs) in epithelia: from absorption to cell signaling

  2007cited by this paper
• Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney.

  2007cited by this paper
• Lymphatic vessels transition to state of summation above a critical contraction frequency.

  2007cited by this paper
• Role of CNT3 in the transepithelial flux of nucleosides and nucleoside‐derived drugs

  2007cited by this paper
• In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta.

  2007cited by this paper
• Guanosine and Inosine Display Antioxidant Activity, Protect DNA In Vitro from Oxidative Damage Induced by Reactive Oxygen Species, and Serve as Radioprotectors in Mice

  2006cited by this paper
• Localization of equilibrative nucleoside transporters in the rat brain.

  2006cited by this paper
• The legacy of great science: the work of Nobel Laureate Gertrude Elion lives on.

  2006cited by this paper
• Effects of inosine on reperfusion injury after heart transplantation.

  2006cited by this paper
• Insulin restores glucose inhibition of adenosine transport by increasing the expression and activity of the equilibrative nucleoside transporter 2 in human umbilical vein endothelium

  2006cited by this paper
• Extracellular adenosine activates AMP-dependent protein kinase (AMPK)

  2006influential reference
• Oxidant Stress and Damage in Post-Ischemic Mouse Hearts: Effects of Adenosine

  2006cited by this paper
• Nucleoside transporters: from scavengers to novel therapeutic targets.

  2006cited by this paper
• Distribution and Functional Characterization of Equilibrative Nucleoside Transporter-4, a Novel Cardiac Adenosine Transporter Activated at Acidic pH

  2006cited by this paper
• Characterization of novel Na+-dependent nucleobase transport systems at the blood-testis barrier.

  2006cited by this paper
• Adenosine as a metabolic regulator of tissue function: production of adenosine by cytoplasmic 5'-nucleotidases.

  2006cited by this paper
• Bile acids alter the subcellular localization of CNT2 (concentrative nucleoside cotransporter) and increase CNT2-related transport activity in liver parenchymal cells.

  2006cited by this paper
• Gene expression for enzymes and transporters involved in regulating adenosine and inosine levels in rat forebrain neurons, astrocytes and C6 glioma cells

  2006cited by this paper
• Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes

  2006cited by this paper
• Reduced ability to release adenosine by diabetic rat cardiac fibroblasts due to altered expression of nucleoside transporters

  2006cited by this paper
• Subtype-specific regulation of equilibrative nucleoside transporters by protein kinase CK2.

  2005cited by this paper
• D-Glucose upregulates adenosine transport in cultured human aortic smooth muscle cells.

  2005cited by this paper
• Functional Characterization of Novel Human and Mouse Equilibrative Nucleoside Transporters (hENT3 and mENT3) Located in Intracellular Membranes*

  2005cited by this paper
• Expression of concentrative nucleoside transporters SLC28 (CNT1, CNT2, and CNT3) along the rat nephron: effect of diabetes.

  2005cited by this paper
• In vivo inosine protects alveolar epithelial type 2 cells against hyperoxia-induced DNA damage through MAP kinase signaling.

  2005cited by this paper
• Adenosine receptors and the control of endothelial cell function in inflammatory disease.

  2005cited by this paper
• Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia.

  2005cited by this paper
• HIF-1–dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia

  2005cited by this paper
• Hypoxanthine transport in mammalian cells: Cell type-specific differences in sensitivity to inhibition by dipyridamole and uridine

  2005cited by this paper
• The concentrative nucleoside transporter family (SLC28): new roles beyond salvage?

  2005cited by this paper
• Adenosine, neurodegeneration and neuroprotection

  2005cited by this paper
• Isolation and characterization of pigeon breast muscle cytosolic 5'-nucleotidase-I (cN-I).

  2005cited by this paper
• Nucleoside Transport at the Blood-Testis Barrier Studied with Primary-Cultured Sertoli Cells

  2005cited by this paper
• The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference

  2004cited by this paper
• Long Term Endocrine Regulation of Nucleoside Transporters in Rat Intestinal Epithelial Cells

  2004influential reference
• Hypoxia regulates the adenosine transporter, mENT1, in the murine cardiomyocyte cell line, HL-1.

  2004cited by this paper
• (Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) Mammalian Nucleoside Transporters

  2004cited by this paper
• The equilibrative nucleoside transporter family, SLC29

  2004cited by this paper
• Mammalian nucleoside transporters.

  2004cited by this paper
• TISSUE DISTRIBUTION OF CONCENTRATIVE AND EQUILIBRATIVE NUCLEOSIDE TRANSPORTERS IN MALE AND FEMALE RATS AND MICE

  2004cited by this paper
• Inhibition of glucose uptake in murine cardiomyocyte cell line HL-1 by cardioprotective drugs dilazep and dipyridamole.

  2004cited by this paper
• Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cells

  2004cited by this paper
• The Adenosine Transporter, mENT1, Is a Target for Adenosine Receptor Signaling and Protein Kinase Cϵ in Hypoxic and Pharmacological Preconditioning in the Mouse Cardiomyocyte Cell Line, HL-1

  2004cited by this paper
• Distribution of CNT2 and ENT1 transcripts in rat brain: selective decrease of CNT2 mRNA in the cerebral cortex of sleep‐deprived rats

  2004cited by this paper
• The concentrative nucleoside transporter family, SLC28

  2004cited by this paper
• Acute adenosinergic cardioprotection in ischemic-reperfused hearts.

  2003cited by this paper
• Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy†

  2003cited by this paper
• Potential therapeutic targets in the rapidly expanding field of purinergic signalling.

  2002cited by this paper
• Detection and quantification of the soluble form of the human erythropoietin receptor (sEpoR) in the growth medium of tumor cell lines and in the plasma of blood samples

  2002cited by this paper
• Transport characteristics of HL-1 cells: a new model for the study of adenosine physiology in cardiomyocytes.

  2002cited by this paper
• Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes.

  2001cited by this paper
• Purines inhibit poly(ADP‐ribose) polymerase activation and modulate oxidant‐induced cell death

  2001cited by this paper
• Adenosine, adenosine receptors and myocardial protection: an updated overview.

  2001cited by this paper
• Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins.

  2001cited by this paper
• Extracellular formation and uptake of adenosine during skeletal muscle contraction in the rat: role of adenosine transporters

  2001cited by this paper
• Differential expression of human nucleoside transporters in normal and tumor tissue.

  2001cited by this paper
• Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system.

  2001cited by this paper
• Inosine Inhibits Inflammatory Cytokine Production by a Posttranscriptional Mechanism and Protects Against Endotoxin-Induced Shock1

  2000cited by this paper
• Adenosine and nitric oxide in exercise-induced human skeletal muscle vasodilatation.

  2000cited by this paper
• Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in vivo microdialysis study.

  2000cited by this paper
• The effect of muscle contraction on the regulation of adenosine formation in rat skeletal muscle cells

  1999cited by this paper
• Distribution of Equilibrative, Nitrobenzylthioinosine‐Sensitive Nucleoside Transporters (ENT1) in Brain

  1999cited by this paper
• Nucleoside transporters and liver cell growth.

  1998cited by this paper
• Differential expression and regulation of nucleoside transport systems in rat liver parenchymal and hepatoma cells

  1998cited by this paper
• Cloning of the Human Equilibrative, Nitrobenzylmercaptopurine Riboside (NBMPR)-insensitive Nucleoside Transporter ei by Functional Expression in a Transport-deficient Cell Line*

  1998cited by this paper
• Removal of adenosine decreases the responsiveness of muscle glucose transport to insulin and contractions.

  1998cited by this paper
• Signal transduction of ischemic preconditioning.

  1997cited by this paper
• Cloning of a human nucleoside transporter implicated in the Cellular uptake of adenosine and chemotherapeutic drugs

  1997cited by this paper
• Adenosine formation in contracting primary rat skeletal muscle cells and endothelial cells in culture

  1997cited by this paper
• Nucleoside and nucleobase transport systems of mammalian cells.

  1996cited by this paper
• Exchange of purines in human liver and skeletal muscle with short-term exhaustive exercise.

  1994cited by this paper
• Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein.

  1994cited by this paper
• Effect of Inosine on Function and Adenine Nucleotide Content of the Isolated Working Rat Heart: Studies of Postischemic Reperfusion

  1991cited by this paper
• Effect of Dietary Nucleosides on Growth and Maturation of the Developing Gut in the Rat

  1990cited by this paper
• Role of RNA as a dietary source of pyrimidines and purines in immune function.

  1990cited by this paper
• Inhibition of insulin‐stimulated glucose transport in rat adipocytes by nucleoside transport inhibitors

  1988cited by this paper
• Nucleoside transport in cultured mammalian cells. Multiple forms with different sensitivity to inhibition by nitrobenzylthioinosine or hypoxanthine.

  1984cited by this paper
• Adenosine and lipolysis.

  1981cited by this paper
• Adenosine and lipolysis.

  1981cited by this paper
• Positive inotropic response to inosine in the in situ canine heart.

  1977cited by this paper
• Nucleoside transport. I. A mediated process in human erythrocytes.

  1971cited by this paper
• Nucleoside transport. II. Inhibition by p-nitrobenzylthioguanosine and related compounds.

  1971cited by this paper
• Nucleophilic Substitution on S4N4. Reactions with Benzylamines

  1971cited by this paper
• Physiology and pharmacology of the coronary circulation and myocardium, particularly in relation to coronary artery disease.

  1969cited by this paper
• Potassium transport and nucleoside metabolism in human red cells

  1967cited by this paper
• A REVIEW OF SOME ASPECTS OF 5-IODODEOXYURIDINE AND AZAURIDINE.

  1963cited by this paper
• CURRENT STATUS OF CLINICAL INVESTIGATIONS WITH 6-AZAURIDINE, 5-IODO-2'-DEOXYURIDINE, AND RELATED DERIVATIVES.

  1963cited by this paper

• Equilibrative nucleotide transporter ENT3 (SLC29A3): A unique transporter for inherited disorders and cancers.

  2023cites this paper
• Solute Carrier Nucleoside Transporters in Hematopoiesis and Hematological Drug Toxicities: A Perspective

  2022cites this paper
• The synergy between nucleotide biosynthesis inhibitors and antiviral nucleosides: New opportunities against viral infections?

  2022cites this paper
• Magnetic bacterial cellulose nanofibers for nucleoside recognition

  2020cites this paper
• Nuevas implicaciones de los transportadores concentrativos de nucleósidos asociadas a la biología tumolar

  2018influential citation
• The Role of Extracellular Adenosine Generation in the Development of Autoimmune Diseases

  2018cites this paper
• The effect of nucleoside transporters and P-GP on the nasal uptake of Ribavirin

  2018cites this paper
• Disentangling metabolic functions of bacteria in the honey bee gut

  2017cites this paper
• Comparison of the diastereoisomeric excess of uridine, inosine and adenosine cyanohydrins determined by HPLC-DAD and 1H NMR.

  2017cites this paper
• RETRACTED ARTICLE: Modulation of the TGF-β1-induced epithelial to mesenchymal transition (EMT) mediated by P1 and P2 purine receptors in MDCK cells

  2017cites this paper
• Novel regulation of equlibrative nucleoside transporter 1 (ENT1) by receptor-stimulated Ca2+-dependent calmodulin binding.

  2016cites this paper
• Novel nuclear hENT2 isoforms regulate cell cycle progression via controlling nucleoside transport and nuclear reservoir

  2016cites this paper
• Effects of Drug Transporters on Pharmacological Responses and Safety.

  2015cites this paper
• Melatonin overcomes resistance to clofarabine in two leukemic cell lines by increased expression of deoxycytidine kinase.

  2015cites this paper
• Identification of Nucleoside Analogs as Inducers of Neuronal Differentiation in a Human Reporter Cell Line and Adult Stem Cells

  2015cites this paper
• Drug transporters in the nasal epithelia and their contribution in drug delivery

  2014cites this paper
• Structural basis of nucleoside and nucleoside drug selectivity by concentrative nucleoside transporters

  2014cites this paper
• Putative Role of AMPK in Fetal Adaptive Brain Shut-Down: Linking Metabolism and Inflammation in the Brain

  2014cites this paper
• Nucleoside transporters in the purinome.

  2014cites this paper
• Inhibition du transport des analogues nucléosidiques par l'inhibiteur de tyrosine kinase nilotinib

  2013cites this paper
• Vascular adenosine receptors; potential clinical applications.

  2013cites this paper
• Involvement of CD73, equilibrative nucleoside transporters and inosine in rhythm and conduction disturbances mediated by adenosine A1 and A2A receptors in the developing heart.

  2013cites this paper
• Transport of nucleosides in the vcCNT facilitated by sodium gradients from molecular dynamics simulations.

  2013cites this paper
• Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2.4 Å

  2012cites this paper
• Cysteine Cross-linking Defines the Extracellular Gate for the Leishmania donovani Nucleoside Transporter 1.1 (LdNT1.1)*

  2012cites this paper
• 6‐mercaptopurine transport in human lymphocytes: Correlation with drug‐induced cytotoxicity

  2012cites this paper
• Identification of agents that reduce renal hypoxia-reoxygenation injury using cell-based screening: purine nucleosides are alternative energy sources in LLC-PK1 cells during hypoxia.

  2012cites this paper
• Les nucléosides et nucléotides extracellulaires régulent les fonctions hépatiques par le biais d’un système complexe de protéines membranaires

  2011cites this paper
• Analysis of recombinant tagged equilibrative nucleoside transporter 1 (ENT1) expressed in E. coli.

  2011cites this paper
• Deoxycytidine kinase modulates the impact of the ABC transporter ABCG2 on clofarabine cytotoxicity.

  2011cites this paper
• Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-γ inhibition.

  2011cites this paper
• Nucleoside transport inhibitors: structure-activity relationships for pyrimido[5,4-d]pyrimidine derivatives that potentiate pemetrexed cytotoxicity in the presence of α1-acid glycoprotein.

  2011cites this paper
• Extracellular nucleosides and nucleotides regulate liver functions via a complex system of membrane proteins.

  2011cites this paper
• Uridine function in the central nervous system.

  2011cites this paper
• Chemotherapy Effects on the Activities of Some Purine Metabolic Enzymes in Sera of Ovarian Cancer Patients

  2010cites this paper
• Equilibrative nucleoside transporter 1 plays an essential role in cardioprotection.

  2010cites this paper
• Equilibrative Nucleoside Transporter 2 Regulates Associative Learning and Synaptic Function in Drosophila

  2010cites this paper
• Characterization of mammalian equilibrative nucleoside transporters (ENTs) by mass spectrometry.

  2010cites this paper
• Compensatory upregulation of the adenosine system following phenylephrine-induced hypertrophy in cultured rat ventricular myocytes.

  2010cites this paper
• Differential expression of functional nucleoside transporters in non-differentiated and differentiated human endothelial progenitor cells.

  2010cites this paper
• ucleoside transporter expression profiles in human cardiac tissue show striking ndividual variability with overall predominance of hENT 1

  2010cites this paper
• Nucleoside transporter expression profiles in human cardiac tissue show striking individual variability with overall predominance of hENT1.

  2010cites this paper
• Caractérisation fonctionnelle des NTPDASE1, NTPDASE2, NTPDASE8 et de l'ecto-5'-nucléotidase hépatiques

  2009cites this paper
• Hyperbranched PEI with various oligosaccharide architectures: synthesis, characterization, ATP complexation, and cellular uptake properties.

  2009cites this paper
• Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters

  2009cites this paper
• An ab Initio Structural Model of a Nucleoside Permease Predicts Functionally Important Residues*

  2009cites this paper
• SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway.

  2009cites this paper
• ATP and adenosine in the local regulation of water transport and homeostasis by the kidney.

  2009cites this paper
• TGF-beta1 inhibits expression and activity of hENT1 in a nitric oxide-dependent manner in human umbilical vein endothelium.

  2009cites this paper
• Novel purine nucleoside analogues for hematological malignancies.

  2008cites this paper
• Technologies for transporter drug discovery

  2008cites this paper